GSA Capital Partners’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,762
| Closed | -$16K | – | 1599 |
|
|
2024
Q4 | $16K | Sell |
16,762
-22,446
| -57% | -$21.4K | ﹤0.01% | 1556 |
|
|
2024
Q3 | $56K | Buy |
39,208
+24,203
| +161% | +$34.6K | ﹤0.01% | 1516 |
|
|
2024
Q2 | $18K | Buy |
+15,005
| New | +$18K | ﹤0.01% | 1577 |
|
|
2024
Q1 | – | Sell |
-20,674
| Closed | -$39K | – | 1561 |
|
|
2023
Q4 | $39K | Sell |
20,674
-121,494
| -85% | -$229K | ﹤0.01% | 1425 |
|
|
2023
Q3 | $195K | Buy |
142,168
+37,194
| +35% | +$51K | 0.02% | 1292 |
|
|
2023
Q2 | $255K | Buy |
104,974
+62,643
| +148% | +$152K | 0.03% | 1138 |
|
|
2023
Q1 | $244K | Buy |
42,331
+19,755
| +88% | +$114K | 0.02% | 1144 |
|
|
2022
Q4 | $202K | Sell |
22,576
-4,071
| -15% | -$36.4K | 0.03% | 1178 |
|
|
2022
Q3 | $379K | Buy |
+26,647
| New | +$379K | 0.05% | 777 |
|